Campbell Noll L, Zhan Jia, Tu Wanzhu, Weber Zach, Ambeuhl Roberta, McKay Caroline, McElwee Newell
College of Pharmacy, Purdue University, West Lafayette, Indiana.
Indiana University Center for Aging Research, Indianapolis, Indiana.
Pharmacotherapy. 2016 Feb;36(2):196-202. doi: 10.1002/phar.1702. Epub 2016 Feb 1.
To compare the frequencies of barriers to medication adherence reported by ambulatory older adults with a diagnosis of mild cognitive impairment (MCI) and ambulatory older adults with normal cognition.
Cross-sectional study.
Outpatient clinics within a safety-net health care system.
Ambulatory older adults (≥ 65 yrs) with a diagnosis of MCI (96 participants) or normal cognition (104 participants).
Self-reported beliefs and barriers to medication nonadherence were assessed by items from the Morisky Medication Adherence Survey, the Adherence Estimator, and barriers derived from a systematic review of studies in older adults with cognitive impairment. Participants with a diagnosis of MCI had a mean age of 72 years, 77% were female, and 37% were African-American. Participants with normal cognition had a mean age of 76 years, 79% were female, and 47% were African-American. Among all participants, 83% reported the presence of at least one barrier to medication adherence, and 62.5% reported two or more barriers to medication adherence. The most commonly reported barriers were difficulty remembering the amount or time of each medication to take (49%), difficulty opening or reading prescription bottles (42%), feeling worse when taking medications (29%), and trouble affording medications (26%). Considering the multiple comparisons made in this analysis, few significant differences in barrier frequencies were identified between the groups with MCI and normal cognition.
Multiple medication adherence barriers were identified among all participants, including cognitive, physical, and financial barriers, although few significant differences were identified between those with and without MCI. Interventions capable of addressing multiple barriers are required to improve medication adherence in older adults with and without MCI.
比较诊断为轻度认知障碍(MCI)的门诊老年患者与认知正常的门诊老年患者报告的药物治疗依从性障碍的发生率。
横断面研究。
安全网医疗保健系统内的门诊诊所。
诊断为MCI的门诊老年患者(≥65岁,96名参与者)或认知正常的门诊老年患者(104名参与者)。
通过Morisky药物治疗依从性调查、依从性评估器中的项目以及对认知障碍老年患者研究的系统评价得出的障碍,对自我报告的药物治疗不依从的信念和障碍进行评估。诊断为MCI的参与者平均年龄为72岁,77%为女性,37%为非裔美国人。认知正常的参与者平均年龄为76岁,79%为女性,47%为非裔美国人。在所有参与者中,83%报告存在至少一种药物治疗依从性障碍,62.5%报告存在两种或更多药物治疗依从性障碍。最常报告的障碍是难以记住每种药物的服用量或时间(49%)、难以打开或阅读药瓶(42%)、服药时感觉更糟(29%)以及难以负担药物费用(26%)。考虑到本分析中进行的多重比较,MCI组和认知正常组之间在障碍发生率方面几乎没有发现显著差异。
在所有参与者中都发现了多种药物治疗依从性障碍,包括认知、身体和经济障碍,尽管在有MCI和无MCI的患者之间几乎没有发现显著差异。需要有能够解决多种障碍的干预措施来提高有和无MCI的老年患者的药物治疗依从性。